Abstract
Highlights:
This report:
- Describes product segments including drug testing devices by sample
specimen, which includes blood, hair, oral fluid, sweat, and urine
- Offers forecasts by product segment from 2008 through 2013
- Discusses diagnostic technologies discussed including enzyme immunoassays,
enzyme multiplied immunoassay techniques, fluorescence polarization
immunoassays, radioimmuno-assays, and various chromatography techniques
- Includes information on industry structure and the regulatory environment
- Profiles leading manufacturers of drugs of abuse diagnostics.
SCOPE of report
This report contains:
- An overview of drug abuse trends in terms of various geographic regions as
well as drug classes.
- Drug abuse statistics in key regions.
- Analysis of regulatory environments in North, South and Central America,
Europe, and Asia Pacific, and country-wise summaries of national legislation
and policies.
- Drug of abuse testing markets with respect to testing approaches and
sample matrices.
- Technology trends in the drug of abuse testing market.
- Leading players in the market and their key products.
- Sales projections through 2014 for drug of abuse testing markets by sample
matrix and geographic regions.
- Analysis of leading companies and their successful strategies.
METHODOLOGY
The base year of this study is 2007. Market figures are based on the revenues
at the manufacturer' s level and are projected at 2007 dollar value (i.e.,
inflation is not computed into the projection figures). Forecasts are mainly
based on the projections of the marketers. Growth of competing products,
technologies, drug of abuse growth trends, government policies, and trends in
the in vitro diagnostics (IVD) market have also been considered for estimating
the future growth trends.
Data to prepare this study was derived from regulatory agencies, trade
literature, patient support groups, and annual reports of companies and
industry related databases. In addition, discussion with product managers of
diagnostic companies, research executives, academic researchers, and
government agency spokespersons have been conducted for gaining insights about
the market, strategies, and future trends.
INFORMATION SOURCES
The information and analysis presented in this report are based on an
extensive survey of the DOA industry as well as a detailed examination of
published literature and reports obtained from regulatory authorities, medical
research institutions, trade associations, and national and world health
organizations. Key information from the literature was used to obtain expert
opinions on commercial potential and market sizes from industry professionals.